BALDUZZI, ADRIANA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 16.649
AS - Asia 12.091
EU - Europa 8.497
SA - Sud America 1.870
AF - Africa 305
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 8
Totale 39.468
Nazione #
US - Stati Uniti d'America 15.752
SG - Singapore 3.931
IT - Italia 2.547
VN - Vietnam 2.387
CN - Cina 2.053
HK - Hong Kong 1.536
RU - Federazione Russa 1.530
BR - Brasile 1.385
DE - Germania 848
IE - Irlanda 754
SE - Svezia 747
CA - Canada 672
BD - Bangladesh 536
FR - Francia 384
IN - India 377
GB - Regno Unito 373
UA - Ucraina 313
FI - Finlandia 233
ID - Indonesia 189
AR - Argentina 170
KR - Corea 158
TR - Turchia 153
ES - Italia 139
JP - Giappone 129
MX - Messico 122
NL - Olanda 112
IQ - Iraq 111
PL - Polonia 97
ZA - Sudafrica 94
AT - Austria 85
EC - Ecuador 80
PK - Pakistan 73
PH - Filippine 70
CO - Colombia 56
BE - Belgio 48
SA - Arabia Saudita 48
VE - Venezuela 48
CL - Cile 44
CH - Svizzera 41
AU - Australia 39
UZ - Uzbekistan 39
LT - Lituania 38
CZ - Repubblica Ceca 36
IR - Iran 35
GR - Grecia 33
MA - Marocco 32
EG - Egitto 31
IL - Israele 31
PY - Paraguay 31
DK - Danimarca 28
JO - Giordania 28
KE - Kenya 28
AE - Emirati Arabi Uniti 27
ET - Etiopia 25
MY - Malesia 24
TN - Tunisia 24
NP - Nepal 23
PE - Perù 21
UY - Uruguay 21
TW - Taiwan 20
PT - Portogallo 19
JM - Giamaica 18
CR - Costa Rica 15
KZ - Kazakistan 15
TH - Thailandia 15
BG - Bulgaria 13
DO - Repubblica Dominicana 13
DZ - Algeria 13
OM - Oman 13
PA - Panama 13
AZ - Azerbaigian 12
RO - Romania 12
BO - Bolivia 11
HN - Honduras 11
NG - Nigeria 11
AL - Albania 10
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
NZ - Nuova Zelanda 9
TT - Trinidad e Tobago 9
AO - Angola 7
BH - Bahrain 7
GT - Guatemala 7
LA - Repubblica Popolare Democratica del Laos 7
LB - Libano 7
PS - Palestinian Territory 7
NI - Nicaragua 6
NO - Norvegia 6
LV - Lettonia 5
LY - Libia 5
MU - Mauritius 5
SV - El Salvador 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
EU - Europa 4
HR - Croazia 4
HU - Ungheria 4
KG - Kirghizistan 4
KW - Kuwait 4
Totale 39.403
Città #
Ann Arbor 2.176
Singapore 2.083
Ashburn 1.514
Hong Kong 1.501
Fairfield 1.012
San Jose 989
Woodbridge 810
Milan 755
Dublin 733
Ho Chi Minh City 724
Hanoi 599
Wilmington 596
Chandler 524
Houston 499
Toronto 473
Frankfurt am Main 464
Seattle 453
New York 452
Dallas 404
Santa Clara 398
Los Angeles 361
Chicago 338
Hefei 324
Cambridge 288
Dearborn 286
Beijing 271
Jacksonville 265
Princeton 232
Rome 200
The Dalles 197
Lauterbourg 168
Moscow 164
Seoul 146
São Paulo 145
Buffalo 131
Jakarta 131
Council Bluffs 130
Boardman 128
Helsinki 114
Shanghai 114
Lawrence 113
Nanjing 96
Altamura 92
Munich 83
Da Nang 79
San Diego 75
Tokyo 72
Haiphong 71
Orem 71
Rio de Janeiro 65
London 64
Nuremberg 63
Warsaw 63
Montreal 62
Denver 60
Atlanta 54
Naples 54
Turin 52
Baghdad 51
Biên Hòa 50
Columbus 49
Andover 47
Ha Long 47
Chennai 46
Johannesburg 46
Guangzhou 45
Dhaka 42
Lappeenranta 41
Salt Lake City 40
Quận Bình Thạnh 39
Turku 39
Phoenix 38
Dong Ket 37
Fremont 37
Tashkent 37
Brooklyn 36
Lachine 36
New Delhi 36
Mexico City 35
Florence 34
Hải Dương 34
Lissone 34
Poplar 34
Vienna 34
Brussels 33
Changsha 33
Istanbul 33
Kent 33
Nanchang 33
Paris 32
Ankara 31
Stockholm 31
Tianjin 31
Washington 29
Amsterdam 28
Can Tho 28
San Francisco 28
Thái Nguyên 28
Zurich 28
Bologna 27
Totale 24.111
Nome #
ABO incompatibile graft management in pediatric transplantation 703
Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations 539
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 486
Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties 480
Long-term complications after allogeneic hematopoietic stem cell transplantation for pediatric patients with acute leukemia or myelodysplastic syndrome given either a Treosulfan- or a Busulfan-based conditioning regimen: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study 474
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 470
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 456
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 444
Avascular necrosis of the talus in pediatric acute lymphoblastic leukemia: Current concepts 425
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 408
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis 404
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 390
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: Practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group 383
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 368
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 362
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 355
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 353
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 345
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 344
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 335
Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overload 324
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 314
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 311
CD34(+) stem cell recovery after positive selection of "overloaded" immunomagnetic columns 309
State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015 309
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 307
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 304
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 303
Thyroid disorders following hematopoietic stem cell transplantation in childhood: the impact of the conditioning regimen on thyroid dysfunction, volume changes and occurrence of nodules 300
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 295
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 290
Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease 290
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 286
Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up 285
Pelvic ultrasound and pubertal attainment in girls with sexual precocity: the pivotal role of uterine volume in predicting the timing of menarche 276
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 273
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience 272
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 271
Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study 268
Precision-based exercise as a new therapeutic option for children and adolescents with haematological malignancies 266
Pubertal attainment and Leydig cell function following pediatric hematopoietic stem cell transplantation: a three-decade longitudinal assessment 263
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 262
Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life 260
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases 260
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 259
PENTRAXIN 3 PLASMA LEVELS AT GRAFT-VERSUS-HOST DISEASE ONSET PREDICT DISEASE SEVERITY AND RESPONSE TO THERAPY IN CHILDREN GIVEN HEMATOPOIETIC STEM CELL TRANSPLANTATION 257
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission 252
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy 251
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis 251
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience 246
Pentraxin-3 Increases At The Onset Of Graft-Versus-Host Disease In Transplanted Patients 245
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia 244
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study 243
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission 238
Donor selection in Adults and Pediatrics 237
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 236
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation 236
Response to rituximab-based therapy and risk factor analysis in epstein barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: A study from the infectious diseases working party of the european group for blood and marrow transplantation 234
Moebius syndrome and hypopituitarism: a case of multiple pituitary hormone deficiency and revision of the literature 225
Isolated leukopenia in children and adolescents referred to a Pediatric Hematology Clinic 225
The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing 225
Transplant-related toxicity and mortality: An AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia 224
First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia 223
The impact of MRD in HCT for childhood ALL 223
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment 223
Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? 221
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 221
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection 220
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: The impact of the waiting time 218
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study 217
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome 216
Late Adverse Events Following Stem Cell Transplantation in Childhood Acute Lymphoblastic Leukaemia: State of the Art 213
Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (vhr) childhood acute lymphoblastic leukaemia in first complete remission 213
Outcomes of BCP-ALL with hypodiploidy or BCR::ABL1 fusion in children undergoing allogeneic HSCT: results from the FORUM study 210
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG 207
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission 205
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 205
Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now? 203
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation 203
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP) 203
Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach 202
Successful sequential liver and hematopoietic stem cell transplantation in a patient with Fanconi anemia 202
Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation 202
Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment 202
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 201
Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions 201
A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization 199
Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes 198
A novel flow-cytometric based method to assess post-HSCT donor chimerism exploiting RNA hybridization 197
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: Results from a phase III trial 196
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children 196
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) 195
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL 194
Osteopathic treatment and evaluation in the clinical setting of childhood hematological malignancies 193
Tetralogy of Fallot with absent pulmonary valve: definitive diagnosis by two-dimensional echocardiography 191
Letermovir Primary and Secondary Prophylaxis in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplant 189
More precisely defining risk peri-HCT in pediatric ALL: Pre- vs post-MRD measures, serial positivity, and risk modeling 189
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: A new classification from the European society for blood and marrow transplantation 187
Sport therapy: Allenamento di precisione dalla diagnosi al termine del trattamento oncologico in bambini e adolescenti con emopatia maligna [Sport therapy: Precision exercise training from diagnosis to the end of treatment in children/adolescents with malignant hemopathies] 187
Two pregnancies shortly after transplantation with reduced intensity conditioning in chronic myeloid leukemia 183
Totale 27.498
Categoria #
all - tutte 127.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.750 158 231 229 159 78 113 74 86 129 122 130 241
2022/20232.682 318 716 163 186 225 418 53 195 217 25 92 74
2023/20242.385 77 69 133 123 300 544 458 88 238 54 77 224
2024/20256.752 345 882 361 307 455 259 311 244 674 862 752 1.300
2025/202619.042 2.332 1.384 1.289 2.015 1.790 833 2.270 774 1.805 1.719 1.157 1.674
2026/202741 41 0 0 0 0 0 0 0 0 0 0 0
Totale 40.445